My prioritization is justified by the evidence structure itself. Across all supplied papers, the cell types interrogated are neurons (inferior colliculus VGLUT2+/VGAT+ populations, TRAP-tagged neurons, zebrafish pallium neurons), fibroblasts, Drosophila germline, and lymphoblastoid/iPSC-derived cells—never microglia . The only sex-specific findings in the dataset are behavioral/endocrine (prenatal stress and maternal experience in female Fmr1 mice) . Inferring microglial mechanisms from neuron-only data would commit a cell-type fallacy—microglial responses to FMRP loss could differ by sex, but that possibility is untested, not demonstrated.
Confidence: high that the gap is real within this dataset (bar at zero for microglia). What would change my answer: a sex-balanced study quantifying microglial activation, phagocytosis, or scRNA-seq states in Fmr1 models—especially with microglia-specific Fmr1 deletion/rescue—would directly test the hypothesis and could overturn the current 'unknown' verdict. Key blindspot: absence in this dataset does not prove absence in the wider literature; a targeted microglia+Fmr1 search outside these records is warranted.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.